ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 388,30
-0,58%
Dow Jones
41 938,45
0,00%
DAX
20 086,59
-0,67%
Brent Oil
79,955
-0,82%
Bitcoin
90 712,98
-4,00%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Iovance Biotherapeutics Inc (IOVA)

  7. Iovance Biotherapeutics Inc (IOVA) Actualités

IOVA

Iovance Biotherapeutics (IOVA)

Iovance Biotherapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:IOVA
DateHeureSourceTitreSymboleSociété
20/12/202423h00GlobeNewswire Inc.Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:IOVAIovance Biotherapeutics Inc
18/12/202423h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
13/12/202423h16Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IOVAIovance Biotherapeutics Inc
02/12/202423h25Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
26/11/202422h01GlobeNewswire Inc.Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory OfficerNASDAQ:IOVAIovance Biotherapeutics Inc
21/11/202423h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IOVAIovance Biotherapeutics Inc
07/11/202423h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IOVAIovance Biotherapeutics Inc
07/11/202422h01GlobeNewswire Inc.Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024NASDAQ:IOVAIovance Biotherapeutics Inc
31/10/202421h01GlobeNewswire Inc.Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024NASDAQ:IOVAIovance Biotherapeutics Inc
03/09/202423h00GlobeNewswire Inc.Iovance Biotherapeutics to Present at Upcoming ConferencesNASDAQ:IOVAIovance Biotherapeutics Inc
08/08/202422h01GlobeNewswire Inc.Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2024NASDAQ:IOVAIovance Biotherapeutics Inc
29/07/202422h01GlobeNewswire Inc.Iovance Biotherapeutics to Host Second Quarter and First Half 2024 Financial Results Conference Call and Webcast on Thursday, August 8, 2024NASDAQ:IOVAIovance Biotherapeutics Inc
28/06/202413h00GlobeNewswire Inc.Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced MelanomaNASDAQ:IOVAIovance Biotherapeutics Inc
24/05/202422h01GlobeNewswire Inc.Iovance Biotherapeutics to Present at Upcoming Conferences and EventsNASDAQ:IOVAIovance Biotherapeutics Inc
23/05/202423h00GlobeNewswire Inc.Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual MeetingNASDAQ:IOVAIovance Biotherapeutics Inc
17/05/202423h15Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:IOVAIovance Biotherapeutics Inc
09/05/202422h01GlobeNewswire Inc.Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate UpdatesNASDAQ:IOVAIovance Biotherapeutics Inc
01/05/202412h01GlobeNewswire Inc.Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024NASDAQ:IOVAIovance Biotherapeutics Inc
24/04/202422h01GlobeNewswire Inc.Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual MeetingNASDAQ:IOVAIovance Biotherapeutics Inc
04/03/202412h30GlobeNewswire Inc.Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung CancerNASDAQ:IOVAIovance Biotherapeutics Inc
28/02/202422h01GlobeNewswire Inc.Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates NASDAQ:IOVAIovance Biotherapeutics Inc
22/02/202414h45GlobeNewswire Inc.Iovance Biotherapeutics to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Wednesday, February 28, 2024NASDAQ:IOVAIovance Biotherapeutics Inc
21/02/202422h44Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IOVAIovance Biotherapeutics Inc
20/02/202412h30GlobeNewswire Inc.Iovance Biotherapeutics, Inc. Announces Pricing of $211 Million Underwritten Offering of Common StockNASDAQ:IOVAIovance Biotherapeutics Inc
16/02/202421h38GlobeNewswire Inc.Iovance Biotherapeutics to Host Conference Call and Webcast on Friday, February 16, 2024NASDAQ:IOVAIovance Biotherapeutics Inc
16/02/202421h19GlobeNewswire Inc.Iovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced MelanomaNASDAQ:IOVAIovance Biotherapeutics Inc
14/02/202412h16Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IOVAIovance Biotherapeutics Inc
28/12/202313h27IH Market NewsWall Street Highlights: Amazon to Introduce Ads on Prime Video, JD.com Raises Salaries in 2024, and MoreNASDAQ:IOVAIovance Biotherapeutics Inc
27/12/202313h54Dow Jones NewsIovance Shares Fall Premarket As FDA Places Study On Hold After Patient DeathNASDAQ:IOVAIovance Biotherapeutics Inc
27/12/202313h00GlobeNewswire Inc.Iovance Biotherapeutics Announces Clinical Program Update for LN-145 in Non-Small Cell Lung CancerNASDAQ:IOVAIovance Biotherapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:IOVA

Dernières Valeurs Consultées

BIT
F39010
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés